$RUBY

Rubius Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Biotechnology

PRICE

$0.218 โ–ผ-0.547%

Extented Hours

VOLUME

167,258

DAY RANGE

0.2136 - 0.2312

52 WEEK

0.202 - 13.52

Join Discuss about RUBY with like-minded investors

profile
@NoobBot #Crypto4Noobs
recently

**@BillGates:** What a lovely bake, Ruby. You deserve a Paul Hollywood handshake for that one! https://t.co/XwRzaQwkNC https://twitter.com/BillGates/status/1509224891903479809

114 Replies 12 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@NoobBot #Crypto4Noobs
recently

Ruby on Rails creator backpedals about Bitcoin: 'We need crypto' https://cointelegraph.com/news/ruby-on-rails-creator-backpedals-about-bitcoin-we-need-crypto

71 Replies 15 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@Benlax #droscrew
recently

https://www.forbes.com/profile/ruby-lu/?sh=a1854c1ec804

141 Replies 7 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@Benlax #droscrew
recently

met with Ruby Lu today

91 Replies 12 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@DarkPoolAlgo #Dark Pool Charts
recently

SCAN RESULTS - BULLISH BOTTOMS $DISCA, $CHGG, $STNE, $ATVI, $PSX, $AZEK, $ETSY, $FTCH, $POSH, $UAA, $SNAP, $PFGC, $BMRN, $CAT, $BIGC, $AVLR, $RSX, $BKR, $COUP, $STNE, $LI, $LESL, $BMBL, $PTON, $IOVA, $RUBY TOPS $ATVI, $FTCH, $FVRR, $IFT, $SBH, $SONY, $YUM, $CVS, $NVST, $CAT, $SYK, $TDC, $TWLO, $RSX, $AMZN, $ALXN BEARISH $BK, $ELS, $KMX, $MCK, $NIO, $WFC, $NVDA, $TLT, $VALE, $INFY

104 Replies 7 ๐Ÿ‘ 7 ๐Ÿ”ฅ

SO
@soheil.n #StockTraders.NET
recently

watchlist: $AAL, $AMC, $JWN, $RUBY, $VIAC

101 Replies 11 ๐Ÿ‘ 12 ๐Ÿ”ฅ

BR
@brAli #StockTraders.NET
recently

why she up soo much RUBY

82 Replies 14 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

what is up with $RUBY?

89 Replies 6 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@thegiz18 #ivtrades
recently

Big turnaround in $RUBY on release of drug study from $24 to $14, trade what you see, not what you think

117 Replies 13 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@thegiz18 #ivtrades
recently

$RUBY up 35% ahead of drug study update today, worth watching move after release

121 Replies 14 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@Milpower1967 #ivtrades
recently

I have to run. Lunch date with missus. Sold the crap out of cash secured puts on $FTFT, $EBON, and $MARA after closing $RUBY CSPs.

138 Replies 11 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@Milpower1967 #ivtrades
recently

$RUBY finally paying off for me 65% profit and am closing at .45 and below. Bam.

113 Replies 8 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@Milpower1967 #ivtrades
recently

$RUBY 3/19 $7.50 and $5 puts are insane right now. All over the place and there is NO WAY they should be paying 35% for two weeks of holding. So, am watching and trying to scalp CSPs at both of those strikes.

142 Replies 14 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@Milpower1967 #ivtrades
recently

$RUBY is STILL misprinting it's 3/19 $7.50 puts. Price is UP today, yet the puts are also up. No. More shenanigans. Make them pay.

143 Replies 6 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@Milpower1967 #ivtrades
recently

Heads up $RUBY puts prices are wrong. No real change, yet puts increased in value. Am selling puts on it now.

138 Replies 9 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@Neptune5045 #StockTraders.NET
recently

covered rest of $RUBY and $VERU need a nap

131 Replies 9 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@Neptune5045 #StockTraders.NET
recently

Had some nice adds on $RUBY welp didnt alert was in a video call

43 Replies 10 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@Neptune5045 #StockTraders.NET
recently

$RUBY 8.8 is my target

86 Replies 12 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@Neptune5045 #StockTraders.NET
recently

I have half left $RUBY

117 Replies 11 ๐Ÿ‘ 12 ๐Ÿ”ฅ

WI
@WINTERTRADE #StockTraders.NET
recently

had a good avg on $ruby but all covered .. i dont know why i covered

135 Replies 8 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@Neptune5045 #StockTraders.NET
recently

cov 1/2 $RUBY

47 Replies 14 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@Neptune5045 #StockTraders.NET
recently

ss $RUBY starter

49 Replies 11 ๐Ÿ‘ 15 ๐Ÿ”ฅ

Key Metrics

Market Cap

19.81 M

Beta

1.62

Avg. Volume

500.06 K

Shares Outstanding

90.37 M

Yield

0%

Public Float

0

Next Earnings Date

2023-02-23

Next Dividend Date

Company Information

Rubius Therapeutics is a clinical-stage biopharmaceutical company developing a new class of medicines called Red Cell Therapeuticsโ„ข. The Company's proprietary RED PLATFORMยฎ was designed to genetically engineer and culture Red Cell Therapeuticsโ„ข that are selective, potent and off-the-shelf allogeneic cellular therapies for the potential treatment of several diseases across multiple therapeutic areas.

CEO: Pablo Cagnoni

Website:

HQ: 399 Binney St Ste 300 Cambridge, 02142-1038 Massachusetts

Related News